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Background: Menstruation was presented as a result of inflammatory process. The total and 
relative numbers of the endometrial immunocompetitive cells vary during the different phases of 
the menstrual cycle. The aim of this morphological study is to make a contribution in 
understanding different distribution of leukocyte types during proliferative and secretory phase 
of normal menstrual cycle. 
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Materials and methods: The study included 40 women (20 in proliferative and 20 in secretory 
phase of the menstrual cycle). Exploratory curettage performed as preoperative preparation due 
to uterine myomas. Immunophenotyping was performed by immunoalkaline phosphatase 
(APAAP) using monoclonal antibodies: CD15, CD 20, CD30, CD45 RO, CD56, CD57 and 
CD68. The results were statistically analyzed using SPSS 20.0 software. 
Results: NK cells are dominant during secretory, and CD45RO T lymphocytes are dominant 
during proliferative phase of the menstrual cycle. During the secretory phase of menstrual cycle, 
leukocytes make 30% of total endometrial cells. NK cells (CD56+ bright subpopulation), 
activated T lymphocytes, macrophages and B lymphocytes significant increase in their number 
during the secretory phase of menstrual cycle.  
Conclusions: Significantly changes in endometrial leukocyte populations during proliferative 
and secretory phase of the menstrual cycle are emphasized. Changes in dominance of different 
leukocyte subpopulations are determined by hormonal and microenvironmental changes in 
modulatory factors that have not yet been fully explained. 





Menstruation is very unusual physiological process specific to some species of animals, 
including humans. Menstruation was presented as a result of inflammatory process by Finn in 
1986. This hypothesis was based on the characteristics of endometrium during the late secretory 
phase – the presence of the oedema; the influx of migratory cells; the presence of the decidual 
cells that have some characteristics representative for granulation tissue fibroblasts [10]. 
The human endometrium is dynamic tissue and its cellular composition changes 
according to hormonal changes during menstrual cycle. After the menstrual bleeding, the next 
phase is endometrial reepithelialization. This process is initiated by stem cells in endometrial 
glands located in the basalis layer, but also from residual rafts of the luminal epithelium. Mitosis 
of the stromal fibroblasts and cells in the blood vessels wall leads to the enlargement of the 
endometrial wall thickness during the proliferative phase. During the next, secretory phase of the 
menstrual cycle, many endoemetrial cell types changes, but decidualization of some stromal cells 
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is the most characteristic. In the absence of the pregnancy, endometrial wall becomes reducted in 
thickness that follows menstrual bleeding. Cellular changes are linked with hormonal changes. 
The endometrial proliferative phase is stimulated by ovarian follicular estradiol, but the secretory 
phase is stimulated by luteal progesteron. As luteolysis begins, estradiol and progesterone levels 
fall and premenstrual phase begins. It happens two days before menstrual bleeding. The total and 
relative numbers of the endometrial cells vary during the different phases of the menstrual cycle.  
[19,20,24].   
It is well known that, so called, "endometrial leukocyte infiltration" happens 
premenstrually. Precise immunological roles of different leukocyte types during different phases 
of the menstrual cycle are still under investigation. This type of cells achieves 40% of stromal 
cells in some phases of the menstrual cycle [1]. The aim of this morphological study is to make a 
contribution in understanding different distribution of leukocyte types during proliferative and 
secretory phase of normal menstrual cycle.      
 
Materials and Methods 
This study included 20 patients in the proliferative phase and 20 patients in the secretory 
phase of the menstrual cycle. The patients aged between 25 and 40 years. Tissue samples were 
obtained by exploratory curettage due to preoperative preparation. Indication for operative 
procedure was uterine myoma (5 to 10 cm in size). Menstrual cycle phase was determined by 
transvaginal ultrasound and based on endometrial morphology, the ovarian follicle or corpus 
luteum presence.  
Curettings were fixed in 10% formaldehyde solution during 24 hours. Afterward, tissue 
samples were blocked to paraffin following routine histological procedures. Thin tissue sections 
(5 μm) were stained using the hematoxylin-eosin method. Immunophenotyping was performed 
using immuno-alkaline phosphatase method (APAAP). The APAAP technique is an indirect 
method which utilizes a pre-formed, cyclic enzyme anti-enzyme immuno complex composed of 
three enzyme molecules (alkaline phosphatase) and two antibody molecules. The technique was 
visualized by using red dye (Fast Red TR). Antigen retrieval was achieved by proteolitic 
digestion. The following monoclonal antibodies (Dako-Agilent Technologies, Denmark) were 
used: CD15 (clone: C3D-1, mouse anti-human antibody, dilution 1:20, marker for leukocytes); 
CD20 (clone: L26, mouse anti-human antibody, dilution 1:300, marker for B lymphocytes); 
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CD30 (clone: Ber H2, mouse anti-human antibody, dilution 1:200, marker for activated cells); 
CD45 RO (clone: UCHL1, mouse anti-human antibody, dilution 1:400, marker for T 
lymphocytes); CD56 (clone: 123C3, mouse anti-human antibody, dilution 1:200, marker for 
natural killer cells - NK cells) and CD57 (clone: TB01, mouse anti-human antibody, dilution 
1:200, markers for natural killer cells - NK cells); CD68 (clone: PG-M1, mouse anti-human 
antibody, dilution 1:200, marker for macrophages). Visualization of the reaction was performed 
using New Fuchsin. Positive reaction was visualized as bright red deposits. A cell count was 
performed under light microscope with 400x magnification and A100 test system. The number of 
cells was determined by standard method - at 10 representative high-power fields (10 HPFs).  
The results were statistically analyzed using SPSS 20.0 software (IBM Corp. Released 
2011. IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp.). Statistical 
significance was tested by Student’s t-test and t-test with method for corrective approximation by 




An average value and percentage of the leukocyte population and average number of 
cells in the endometrial tissue in the proliferative and in the secretory phase of the menstrual 
cycle (in 10 HPFs) is shown in the table 1. There is significantly less number of leukocytes in the 
proliferative phase in relation to secretory phase (p < 0.001).   
Number of CD56 positive NK cells was significantly higher in the secretory phase of 
menstrual cycle (p < 0.001). In the endometrial tissue, during the both analyzed menstrual cycle 
phases, CD57 positive NK cells were not noted (figure 1). 
Two different subsets of CD56 positive NK lymphocytes have been identified in the 
endometrial tissue – CD56 positive dim and bright NK lymphocytes. The percentage of these 
immunoreactive subsets has changed depends on the cycle phase. In the proliferative phase only 
CD56 positive dim cells were noted, but in the secretory phase CD56 positive bright cells were 
dominant (figure 2). 
Average number and percentage of T lymphocyte subpopulations is significantly 
different between analyzed phases of the menstrual cycle (figure 1). CD30 positive, activated T 
lymphocytes are statistically higher in the secretory, but CD45RO positive T lymphocytes are 
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statistically higher in the proliferative phase of the menstrual cycle (p < 0.001). In the both 
analyzed phases, CD45RO positive T lymphocytes were dominant subpopulation. 
Average number of macrophages (CD68 positive cells) was significantly higher in the 
secretory phase (p < 0.05) (figure 3). 
Average number and percentage of B lymphocytes (CD20 positive cells) in the 
endometrial tissue was significantly higher in the secretory phase (p < 0.001) (figure 1).   
Frequency percentage of all analyzed subpopulations of leukocytes is given in figure 1. 
During secretory and proliferative phases, NK cells and CD45RO T lymphocytes are dominant 
in the endometrial tissue. NK cells are dominant during secretory, and CD45RO T lymphocytes 
are dominant during proliferative phase of the menstrual cycle.    
Figure 4 represents immunohistochemical staining of T lymphocytes, macrophages, NK 
cells and B lymphocytes in endometrium during secretory phase of the menstrual cycle.     
 
Discussion 
During the normal menstrual cycle, uterine leukocytes provide immune protection for the 
uterine mucosa. These cells influence on endometrial remodeling, decidualization, implantation 
of the embryo or facilitate the process of menstruation. It is noted that macrophages, neutrophils 
and NK cells are engaged in the endometrium during the secretory phase and prepare the tissue 
for menstruation [5,22,25]. During the late secretory phase, macrophages, eosinophils, 
neutrophils, granular lymphocytes, B and T lymphocytes and mast cells represent up to 40% of 
total endometrial stromal cells [24]. Recent study confirmed this state, but total number of 
leukocytes made 30% of total endometrial cell number in secretory phase. Number of total cells 
significantly increases in proliferative phase, but percentage of leukocytes significantly increases 
in secretory phase of the menstrual cycle. Increased number of macrophages and neutrophils 
produce neutral antimicrobial proteins and provide microbial protection at the time of disrupted 
epithelial barrier [16,17]. It is interesting that mast cells have relatively constant number during 
the menstrual cycle, but elevated expression of the extracellular tryptase suggests increased 
activation of these cells. Mast cells release different mediators that induce tissue edema and 
activate proteolytic enzymes and matrix metalloproteinases which induces degradation of 
extracellular matrix [24]. During the menstruation, it is emphasized increased number of T and B 
cells, macrophages, NK cells and plasma cells in uterine drainage lymph nodes, too. At the same 
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time, number of stromal cells in the endometrium is increased. This suggests that menstruation is 
associated with specific adaptive immunological activation [1]. 
Endometrial NK cells, as known as endometrial granular lymphocytes, have different 
subtypes (CD56+, CD2+/-, CD 38+, CD16-, CD3-) and this type of cells is the most numerous 
hematopoietic cells in the endometrium [4]. Their number increase in stroma during the secretory 
phase up to 15% [24] or 25 % [4] of total cell number. Recent study demonstrated significantly 
increase of NK cells during secretory phase of the menstrual cycle. NK CD56+ cells made 
25.9% of leukocytes during proliferative, but 44.3% of leukocytes during secretory phase. NK 
CD56+ cells have two subsets: NK CD56 dim cells that have high level of CD 56 expression 
(90% of NK cells in peripheral blood) and NK CD56 bright cells that have low level of CD 56 
expression (10% of NK cells in peripheral blood) [9]. NK CD56 dim cells show higher level of 
cytotoxicity and NK CD56 bright cells are source of uterine NK cells and immunomodulatory 
cytokines [8]. In the recent study, NK CD57+ cells were not noted in endometrium. It was the 
first difference in comparison with peripheral NK cells. Otherwise, NK CD56 dim cells are NK 
cells of proliferative and NK CD56 bright cells are NK cells of the secretory phase of the 
menstrual cycle. Endometrial granular lymphocytes contain perforin, granzime A, T cell 
intraplasmic antigen and some metalloproteinases that are involved in cell and tissue degradation 
[18].  
Subsets of T cells (CD8+ and CD4+) have a ratio in endometrium inverted in comparison 
with their ratio in the peripheral blood. Endometrial ratio is 66% of CD8+ T cells (cytotoxic 
phenotype) and 33% CD4+ T cells (helper phenotype). T cells are cytolitically active during the 
proliferative phase, but this activity decreases in the secretory phase of the menstrual cycle. It is 
suggested that progesterone can down-regulate this activity [30]. Some previous studies showed 
that CD8+ T cells are highly activated during the proliferative phase. This activation, that is 
especially high during the early- and mid-proliferative phase, could be of crucial importance for 
clearance of potential antigens and residual debris in the uterine cavity. T cell activity decreases 
due to increasing estrogen levels prior to ovulation [15]. Recent study emphasized significantly 
increase of total T cells number during proliferative phase, but significantly increase of activated 
T cells number during secretory phase. This result could be a consequence of unseparated 
fractions of T cells. During the menstrual cycle, B lymphocytes are noted in low numbers, but 
perimenstrually these cells are organized in clusters in endometrial stroma [24]. Recent study 
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confirmed B lymphocytes in percentage less than 2% of total leukocytes during the menstrual 
cycle. In secretory phase, percentage of B cells is significantly increased in comparison with 
proliferative phase (1.6% vs. 0.3%). 
Neutrophils, eosinophils and macrophages are detectable in very small number in normal 
endometrium during most of the cycle, but perimenstrually, their number increases. Number of 
neutrophils, as well as macrophages, achieves 6–15% of total cell number [24]. Interferon–
gamma is detected in human endometrial intraepithelial neutrophils and this mediator is activator 
of macrophages and suggesting an interaction between this types of leukocytes [11,31]. 
Macrophages in the recent study showed increase in absolute number during secretory phase, but 
in percentage comparison with other immunocompetitive cells, percentage of macrophages 
decrease during secretory phase. During menstrual cycle, macrophages made less than 5% of 
total cell number. Macrophages are found at sites of active tissue remodeling, as an immune cells 
of chronic inflammatory lesions [3].  
Migratory endometrial leukocytes may influence vascular permeability. Disregulation of 
the leukocyte activity and disbalance in its number is reported in women with heavy menstrual 
bleeding [21]. T regulatory cells have been shown to help to establish allotolerance and 
successful pregnancy [13]. Elevated levels of activated NK cells and increased cytotoxicity are 
noted in recurrent pregnancy loss [7,27]. 
Number of leukocytes in the endometrium can be regulated in two ways: as a poliferation 
in situ or as a migratory process from the peripheral circulation. Some human uterine leukocytes, 
as macrophages, T cells or endometrial lymphocytes, express neither oestrogen nor progesteron 
receptors, so the effect of these steroid hormones on these types of immune cells could be 
indirect [18]. It is still under the investigation if immune cells migration from the peripheral 
circulation to the endometrium is mediated by factors such as chemokines or adhesion 
molecules. Some monocyte chemotactic proteins are localized in the perivascular cells and show 
intense immunostaining in the late secretory and proliferative phases of the menstrual cycle. 
Besides that, these proteins showed wide individual variety in staining [14]. In endometrium, 
during the late secretory phase, eotaxin is detected in the perivascular cells [32]. It is postulated 
that chemokines included in the control of immune cells influx prior to menstruation and their 
moving to the subepitheial space. In this location, immune cells are capable for appropriate 
activity [26]. Various adhesion molecules are investigated and it is concluded that their site-
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specific expression could be related to the distinct distribution of endometrial leukocytes [29]. 
There are some studies that proved leukocyte proliferation in situ in the late secretory phase. 
Some cells (CD45+, CD3+, CD11c+, CD56+) express proliferation markers in this period. In 
vitro studies demonstrated proliferation of CD56+ cells in the presence of the endometrial 
stromal cells and progesterone [12,28]. During the mid- and late secretory phase, human 
endometrial and stromal cells reaching the peak of production interleukin-1 and tumor necrosis 
factor alpha, as well as some mediators that are steroid-hormon modulated, such as 
prostaglandins, endothelin, nitric oxide, transforming growth factor beta. All interactions 
between endometrial immune cells and these modulators are not completely defined, but these 
factors may have a role in the migration, proliferation and activation of immune cells [24]. 
Leukocytes have a potential role in contributing to menstruation. Leukocytes produce 
factors that can directly or indirectly contribute to menstruation. Direct effects are tissue 
degradation via producing proteolytic enzymes. Indirect effects are evident in the stimulation of 
adjacent cells to produce other active enzymes, such as plasminogen activator produced by 
macrophages [23,24,32]. Besides the role in tissue degradation, leukocytes give a contribution in 
processes of endometrial reparation. Macrophages produce fibroblast-growth factor, vascular 
endothelial-growth factor, transforming growth factor alpha and beta, activin beta. Lymphocytes 
produce fibroblast growth factor and leukocyte-derived growth factor. Tryptase produced by 
mast cells is mitogen for epithelial cells [2,6].  
 
Conclusions 
During the secretory phase of menstrual cycle, leukocytes make 30% of total endometrial 
cells. NK cells (CD56+ bright subpopulation), activated T lymphocytes, macrophages and B 
lymphocytes significant increase their number during the secretory phase of menstrual cycle. 
These changes in dominance of different leukocyte subpopulations could be determined by 
hormonal and microenvironmental changes in modulatory factors.  
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Table 1. Average number and percentage of leukocytes (CD15 positive cells) and average total 
number of cells in the endometrial tissue in different phases of menstrual cycle. 
Menstrual cycle Leukocytes Total number of cells 
Proliferative phase 97.7 ± 18.9 (6%) 1629.8 ± 303.2** 
Secretory phase 116.9 ± 11.45 (30%)**  389.7 ± 38.17  
**p < 0.001 
 
Figure 1. Percentage of the present leukocyte subpopulations, depending on the phase of the 





Figure 2. Percentage of NK CD56 positive cells subpopulations in the endometrial tissue in 
different phases of menstrual cycle. 
 
Figure 3. Average number of the macrophages in the endometrial tissue in different phases of 





Figure 4. Presentation of the endometrial immunocompetent cells in the secretory phase of the 
menstrual cycle (400x): A – T lymphocytes (CD45RO positive cells); B – macrophages (CD68 
positive cells); C – NK cells (CD56 positive cells); D – B lymphocytes (CD20 positive cells). 
 
 
